PHILADELPHIA, Feb. 3, 2016 /PRNewswire/ -- According to a new report from the Intellectual Property & Science business of Thomson Reuters, there are a total of seven new therapeutics currently in the new drug development pipeline that should enter the market this year and surpass $1...